Liver Resection for Hepatocellular Carcinoma in a Hepatitis B Endemic Area
暂无分享,去创建一个
A. Bartlett | J. McCall | E. Gane | M. Yeong | J. Koea | A. Holden | N. Gurusinghe
[1] M. Sherman,et al. Screening for hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[2] W. Lau,et al. A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.
[3] J. Lochner,et al. What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B? , 2006, The Journal of family practice.
[4] B. Portmann,et al. Selection of patients with hepatocellular carcinoma for liver transplantation , 2006, The British journal of surgery.
[5] F. Greene,et al. Controversies in staging of hepatocellular carcinoma. , 2005, Journal of hepato-biliary-pancreatic surgery.
[6] V. Mazzaferro,et al. Resection, transplantation, either, or both? Other pieces of the puzzle , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] K. Chow,et al. Liver transplantation for hepatocellular carcinoma in New Zealand: a prospective intent-to-treat analysis. , 2005, The New Zealand medical journal.
[8] M. Bailey,et al. Survival in hepatocellular carcinoma: Impact of screening and etiology of liver disease , 2005, Journal of gastroenterology and hepatology.
[9] R. Adam,et al. Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy? , 2005, Annals of surgery.
[10] C. Broelsch,et al. Liver resection for hepatocellular carcinoma in non‐cirrhotic liver without underlying viral hepatitis , 2005, The British journal of surgery.
[11] S. Fan,et al. Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy? , 2004, Annals of surgery.
[12] Zhao-You Tang,et al. Randomized controlled trial of screening for hepatocellular carcinoma , 2004, Journal of Cancer Research and Clinical Oncology.
[13] B. Dousset,et al. Résection du carcinome hépatocellulaire sur cirrhose avant transplantation hépatique : une stratégie justifiée ? , 2004 .
[14] E. Abdalla,et al. Resection Prior to Liver Transplantation for Hepatocellular Carcinoma , 2003, Annals of surgery.
[15] K. Boudjema,et al. Adjuvant intra‐arterial injection of iodine‐131–labeled lipiodol after resection of hepatocellular carcinoma , 2003, Hepatology.
[16] J. Dickinson,et al. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. , 2003, The Cochrane database of systematic reviews.
[17] A. Gardini,et al. Liver Resection for Hepatocellular Carcinoma on Cirrhosis: Univariate and Multivariate Analysis of Risk Factors for Intrahepatic Recurrence , 2003, Annals of surgery.
[18] V. Vilgrain,et al. Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial , 2003, Annals of surgery.
[19] Steven A Curley,et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. , 2002, Archives of surgery.
[20] M. Sherman,et al. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto , 2002, Gut.
[21] 中国肝脏专家组. The unified terminology of liver anatomy and resections , 2002 .
[22] J. McCall,et al. Liver resections in Auckland 1998-2001: mortality, morbidity and blood product use. , 2001, The New Zealand medical journal.
[23] M. Makuuchi,et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. , 2000, Journal of the American College of Surgeons.
[24] A. Zbar,et al. Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[25] Bernardino,et al. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma , 2000, Hepatology.
[26] J. Bruix,et al. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.
[27] C. Lo,et al. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test , 1999, The British journal of surgery.
[28] W. Jarnagin,et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. , 1999, Annals of surgery.
[29] W. Yeo,et al. Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial , 1999, The Lancet.
[30] F. Izzo,et al. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients , 1998, Hepatology.
[31] J. Bruix,et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. , 1996, Annals of surgery.
[32] K. Ishak,et al. Histological grading and staging of chronic hepatitis. , 1995 .
[33] C. Scudamore,et al. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. , 1992, American journal of surgery.
[34] R. Pugh,et al. Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.
[35] H. Edmondson,et al. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.
[36] B. Kerr,et al. Improved survival with screening for hepatocellular carcinoma in chronic hepatitis B: preliminary results of a national surveillance programme , 2004 .
[37] J. Furui,et al. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. , 2002, Surgery.
[38] M. Makuuchi,et al. The Brisbane 2000 terminology of liver anatomy and resections. , 2000 .
[39] Bellia Mario,et al. Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80) , 2000 .
[40] D. Machin,et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. , 1999, Lancet.
[41] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.